Details:

Alternative Title:
Mol Ther Methods Clin Dev
Publisher's site:
http://dx.doi.org/10.1016/j.omtm.2018.07.007
Personal Author:
Sayedahmed, Ekramy E. ; Hassan, Ahmed O. ; Kumari, Rashmi ; Cao, Weiping ; Gangappa, Shivaprakash ; ... More +
Sayedahmed, Ekramy E. ; Hassan, Ahmed O. ; Kumari, Rashmi ; Cao, Weiping ; Gangappa, Shivaprakash ; York, Ian ; Sambhara, Suryaprakash ; Mittal, Suresh K. Less -
Description:
Several human and nonhuman adenovirus (AdV) vectors including bovine AdV type 3 (BAdV-3) were developed as gene delivery vectors to supplement and/or elude human AdV (HAdV)-specific neutralizing antibodies (vector immunity). Here we evaluated the vaccine immunogenicity and efficacy of BAdV-3 vector (BAd-H5HA) expressing hemagglutinin (HA) of a H5N1 influenza virus in a dose escalation study in mice with the intranasal (IN) or intramuscular (IM) route of inoculation in comparison with the HAdV type C5 (HAdV-C5) vector (HAd-H5HA) expressing HA of a H5N1 influenza virus. Dose-related increases in the immune responses were clearly noticeable. A single IM inoculation with BAd-H5HA resulted in enhanced cellular immune responses compared with that of HAd-H5HA and conferred complete protection following challenge with a heterologous H5N1 virus at the dose of 3 × 10| plaque-forming units (PFUs), whereas a significant amount of influenza virus was detected in the lungs of mice immunized with 1 × 10| PFUs of HAd-H5HA. Similarly, compared with that of HAd-H5HA, a single IN inoculation with BAd-H5HA produced significantly enhanced humoral (HA-specific immunoglobulin [IgG] and its subclasses, as well as HA-specific IgA) and cellular immune responses, and conferred complete protection following challenge with a heterologous H5N1 virus. Complete protection with BAd-H5HA was observed with the lowest vaccine dose (1 × 10| PFUs), but similar protection with HAd-H5HA was observed at the highest vaccine dose (1 × 10| PFUs). These results suggest that at least 30-fold dose sparing can be achieved with BAd-H5HA vector compared with HAd-H5HA vaccine vector.
Subject:
[+]
Adenoviral Vector
Article
Avian Influenza
Bovine Adenoviral Vector
Dose Sparing
Enhanced Immunogenicity And Protection
Human Adenoviral Vector
Route Of Immunization
Universal Influenza Vaccine

Source:
Mol Ther Methods Clin Dev. 2018; 10:210-222.
Pubmed ID:
30101154
Pubmed Central ID:
PMC6082999
Document Type:
Journal Article
Funding:
R01 AI059374/AI/NIAID NIH HHS/United States
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:5d342e28460284bdbdf2b385a6bb078a1fb665f9802e44aca3d346dc388da8cc
File Type:

Supporting Files

• 	gr2.gif	gif
  	gr2.jpg	jpeg
  	gr3.gif	gif
  	gr3.jpg	jpeg
  	gr4.gif	gif
  	gr4.jpg	jpeg
  	gr5.gif	gif
  	gr5.jpg	jpeg
  	gr6.gif	gif
  	gr6.jpg	jpeg
  	gr1.gif	gif
  	gr7.gif	gif
  	gr7.jpg	jpeg
  	gr8.gif	gif
  	gr8.jpg	jpeg
  	gr9.gif	gif
  	gr9.jpg	jpeg
  	main.nxml	xml
  	mmc1.pdf	pdf
  	gr1.jpg	jpeg
  	gr10.gif	gif
  	gr10.jpg	jpeg
  	gr11.gif	gif
  	gr11.jpg	jpeg
  	gr12.gif	gif
  	gr12.jpg	jpeg

More +